Literature DB >> 2187868

Partial purification and characterization of bovine liver aspartyl beta-hydroxylase.

R S Gronke1, D J Welsch, W J VanDusen, V M Garsky, M K Sardana, A M Stern, P A Friedman.   

Abstract

In vitro hydroxylation of aspartic acid has recently been demonstrated in a synthetic peptide based on the structure of the first epidermal growth factor domain in human factor IX (Gronke, R. S., VanDusen, W. J., Garsky, V. M., Jacobs, J. W., Sardana, M. K., Stern, A. M., and Friedman, P. A. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 3609-3613). The putative enzyme responsible for the posttranslational modification, aspartyl beta-hydroxylase, has been shown to be a member of a class of 2-ketoglutarate-dependent dioxygenases, which include prolyl-4- and lysyl-hydroxylases. In the present study, we describe the solubilization with nonionic detergent of the enzyme from bovine liver microsomes and its purification using DEAE-cellulose followed by heparin-Sepharose. No additional detergent was required during purification. The partially purified enzyme preparation was found to contain no prolyl-4- or lysyl-hydroxylase activity. Using a synthetic peptide based on the structure of the epidermal growth factor-like region in human factor X as substrate, the apparent Km values for iron and alpha-ketoglutarate were 3 and 5 microM, respectively. The enzyme hydroxylated the factor X peptide with the same stereospecificity (erythro beta-hydroxyaspartic acid) and occurred only at the aspartate corresponding to the position seen in vivo. Furthermore, the extent to which either peptide (factor IX or X) was hydroxylated reflected the extent of hydroxylation observed for both human plasma factors IX and X.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187868

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.

Authors:  Arihiro Aihara; Chiung-Kuei Huang; Mark J Olsen; Qiushi Lin; Waihong Chung; Qi Tang; Xiaoqun Dong; Jack R Wands
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

2.  Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Sasmita Mishra; Howard Safran; Kevin P Charpentier; William Martin; Anne S De Groot; Stephen H Gregory; Jack R Wands
Journal:  Vaccine       Date:  2015-01-25       Impact factor: 3.641

3.  Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.

Authors:  Takehiro Noda; Masafumi Shimoda; Vivian Ortiz; Alphonse E Sirica; Jack R Wands
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

4.  Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma.

Authors:  L Lavaissiere; S Jia; M Nishiyama; S de la Monte; A M Stern; J R Wands; P A Friedman
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

5.  A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases.

Authors:  S Jia; K McGinnis; W J VanDusen; C J Burke; A Kuo; P R Griffin; M K Sardana; K O Elliston; A M Stern; P A Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinoma.

Authors:  Martin Luu; Edmond Sabo; Suzanne M de la Monte; Wesley Greaves; JiYi Wang; Rosemarie Tavares; Lelia Simao; Jack R Wands; Murray B Resnick; LiJuan Wang
Journal:  Hum Pathol       Date:  2009-02-05       Impact factor: 3.466

Review 7.  Vitamin C: update on physiology and pharmacology.

Authors:  J Mandl; A Szarka; G Bánhegyi
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

8.  Beta-cell alpha-ketoglutarate hydroxylases may acutely participate in insulin secretion.

Authors:  Michael J Fallon; Michael J MacDonald
Journal:  Metabolism       Date:  2008-08       Impact factor: 8.694

9.  Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803.

Authors:  Luke A McNeill; Kirsty S Hewitson; Timothy D Claridge; Jürgen F Seibel; Louise E Horsfall; Christopher J Schofield
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

10.  Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase.

Authors:  Lennart Brewitz; Yu Nakashima; Christopher J Schofield
Journal:  Chem Sci       Date:  2020-12-07       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.